Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Est. Listeners
Based on iTunes & Spotify (publisher stats).
- Per-Episode Audience
Est. listeners per new episode within ~30 days
10,001 - 25,000 - Monthly Reach
Unique listeners across all episodes (30 days)
5,001 - 25,000 - Active Followers
Loyal subscribers who consistently listen
5,001 - 15,000
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 10 epsHost
Recent guests
Recent episodes
Systemic Treatment of Thyroid Cancer Guideline
Apr 1, 2026
23m 25s
Patient-Clinician Communication Guideline Update
Mar 10, 2026
31m 22s
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer Guideline Update
Feb 26, 2026
28m 55s
White Blood Cell Growth Factors Guideline Update
Feb 25, 2026
23m 22s
Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2026.3.0 Part 2
Feb 3, 2026
19m 36s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 4/1/26 | Systemic Treatment of Thyroid Cancer Guideline✨ | thyroid cancersystemic treatment+4 | Dr. Nabil Saba | American Society of Clinical OncologyEmory University+2 | — | thyroid cancersystemic treatment+5 | — | 23m 25s | |
| 3/10/26 | Patient-Clinician Communication Guideline Update✨ | patient-clinician communicationoncology guidelines+5 | Dr. Timothy GilliganDr. Calvin Chou | American Society of Clinical OncologyJournal of Clinical Oncology+1 | — | communication skillsoncology+5 | — | 31m 22s | |
| 2/26/26 | Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer Guideline Update✨ | immunotherapytargeted therapy+4 | Dr. Lakshmi RajdevDr. Manish Shah | American Society of Clinical OncologyJournal of Clinical Oncology+2 | — | gastroesophageal adenocarcinomaesophageal squamous cell carcinoma+7 | — | 28m 55s | |
| 2/25/26 | White Blood Cell Growth Factors Guideline Update✨ | hematopoietic colony-stimulating factorscancer treatment+4 | Dr. Bishal GyawaliDr. Tessa Cigler | American Society of Clinical OncologyWhite Blood Cell Growth Factors: ASCO Guideline Update | — | CSFsprimary prophylaxis+7 | — | 23m 22s | |
| 2/3/26 | Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2026.3.0 Part 2✨ | NSCLCdriver alterations+4 | Dr. Sonam Puri | American Society of Clinical OncologyMoffitt Cancer Center+2 | www.asco.org/thoracic-cancer-guidelinesascopubs.org | NSCLCdriver alterations+7 | — | 19m 36s | |
| 2/3/26 | Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2026.3.0 Part 1✨ | stage IV NSCLCliving guidelines+3 | Dr. Joshua Reuss | American Society of Clinical OncologyGeorgetown University+2 | ASCO | NSCLCdriver alterations+3 | — | 18m 03s | |
| 1/20/26 | Systemic Therapy in Patients With mCRPC: ASCO Living Guideline 2026.1✨ | metastatic castration-resistant prostate cancerASCO guidelines+3 | Dr. Mary-Ellen Taplin | American Society of Clinical OncologyDana-Farber Cancer Institute+2 | — | mCRPCADT+5 | — | 13m 37s | |
| 1/6/26 | Treatment of Multiple Myeloma: ASCO-OH (CCO) Living Guideline✨ | multiple myelomatreatment guidelines+4 | Dr. Lisa HicksDr. Joseph Mikhael | American Society of Clinical OncologyOntario Health+2 | — | multiple myelomatreatment options+5 | — | 22m 18s | |
| 12/11/25 | Management of Cancer During Pregnancy Guideline✨ | cancer managementpregnancy+4 | Dr. Alison LorenDr. Ann Partridge | American Society of Clinical Oncology | — | cancer during pregnancyASCO guidelines+3 | — | 34m 50s | |
| 9/18/25 | Management of Antineoplastic Extravasation: ONS-ASCO Guideline✨ | antineoplastic extravasationoncology nursing+3 | Dr. Tanya ThomasDr. Aparna Jotwani | Oncology Nursing SocietyAmerican Society of Clinical Oncology+2 | — | extravasationvesicant agents+5 | — | 13m 28s |
Showing 10 of 10
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
5 placements across 4 markets.
Chart Positions
5 placements across 4 markets.